| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 6 |
| 1 | ADALIMUMAB | 4 |
| 2 | CARBOPLATIN | 4 |
| 3 | FUROSEMIDE | 4 |
| 4 | SIMVASTATIN | 4 |
| 5 | SPIRONOLACTONE | 4 |
| 6 | CEFTRIAXONE | 3 |
| 7 | CEFTRIAXONE SODIUM | 3 |
| 8 | CLONAZEPAM | 3 |
| 9 | GABAPENTIN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOFERSEN | 2 | 0.0035 |
| 1 | RILUZOLE | 1 | 0.0004 |
| 2 | IMIQUIMOD | 1 | 0.0004 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 3 | 0.0004 |
| 4 | FINGOLIMOD HYDROCHLORIDE | 1 | 0.0002 |
| 5 | ALEMTUZUMAB | 2 | 0.0001 |
| 6 | RIFAMPICIN | 1 | 0.0001 |
| 7 | ZIDOVUDINE | 1 | 0.0001 |
| 8 | BLINATUMOMAB | 1 | 0.0001 |
| 9 | EFAVIRENZ | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Benzothiazole [EPC] | 1 | 0.0004 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 2 | Glycopeptide Antibacterial [EPC] | 3 | 0.0000 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 5 | Aldosterone Antagonist [EPC] | 4 | 0.0000 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 4 | 0.0000 |
| 8 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |